glp 1 drugs and cancer The effect of GLP-1R agonists on the medical triad of obesity, diabetes, | Cancer and Metastasis Reviews GLP-1 drugs may reduce the

Loss of Function Glucose-Dependent Insulinotropic Polypeptide Receptor Variants Are Associated With Alterations in BMI, Bone Strength and Cardiovascular Outcomes

doi: 10.1016/S0140-6736(06)69705-5 34 HolstJJ

This hormone plays a key role in regulating blood sugar, appetite, and digestion

Just like managing high blood pressure or diabetes, treating obesity requires ongoing effort and support

As healthcare consumers, we need to talk to our doctors

At the heart of this transformation are GLP-1-based therapies, a class of drugs that has rapidly moved from diabetes treatment into the center stage of obesity care and beyond